Obervational Study on the Effectiveness of Intravitreal Aflibercept in Exudative Age-related Macular Degeneration Patients
Phase of Trial: Phase IV
Latest Information Update: 26 Oct 2016
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 24 Oct 2016 Status changed from recruiting to completed.
- 30 Jun 2016 New trial record
- 01 Jan 2015 Status changed from not yet recruiting to recruiting according to the results published in the Ophthalmic Research.